Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
Tenet Healthcare Corporation
THC
NYSE·Healthcare·Medical - Care Facilities·Mkt cap $16.5B
$204.19
▲ +6.79%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$146.60 - $247.21
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 11.0% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Extensive integrated network of 60 hospitals and 550+ healthcare facilities providing geographic diversification and patient access
- Comprehensive service offerings from primary care to complex quaternary procedures including transplants and specialized surgeries
- Conifer division's healthcare business process expertise creating recurring revenue and cross-selling opportunities
- Scale advantages in purchasing, staffing, and technology implementation across large facility network
Bear Case
1 risk
- Average volatility.
Growth
Stable outlook
Aging U.S. population increasing demand for acute care and specialized medical services
Value
Undervalued - trading well below Healthcare Facilities peers
Momentum
Stable
+1.6% over 3m
Quality
Strong
Excellent business quality
Dividend
None
No dividend
Smart-money signal
Who's buying THC right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Apr 27, 2026
APR 30, 2026
Reported EPS of $4.82 vs $4.21 consensus (+14.5% surprise). Revenue of $5.4B vs $5.4B expected (-0.5%).
EPS surprise · last 4Q
1 of 1 beats
Q2 26
+14.5%
Next: Apr 27, 2026
Revenue trend · last 8Q
—
—
-6%
-3%
+3%
+3%
+9%
+3%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$5.1B
$5.1B
$5.1B
$5.2B
$5.3B
$5.3B
$5.5B
$5.4B
Margins · last 8Q
Gross
16.4%
Operating
16.4%
Profit
13.1%
Wall Street consensus
13 analysts · 92% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
92%
Hold
8%
Sell
0%
Median Price Target
$246.00
▲ +20.5% vs $204.19
Latest: Barclays · $238.00 · May 5, 2026
4 analysts covering